acetilsalicilatna kiselina g.l. pharma 100 mg tablete
g.l. pharma gmbh, schlossplatz 1, lannach, austrija - acetilsalicilatna kiselina - tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg acetilsalicilatne kiseline
dobutamin panpharma 250 mg/20 ml koncentrat za otopinu za infuziju
panpharma, z.i. du clairay, luitre, francuska - dobutaminklorid - koncentrat za otopinu za infuziju - 250 mg/20 ml - urbroj: 1 bočica sa 20 ml sadrži 250 mg dobutamina u obliku 280,2 mg dobutaminklorida
neostigmin panpharma 0,5 mg/ml otopina za injekciju
panpharma, z.i. du clairay, luitre, francuska - neostigminijev metilsulfat - otopina za injekciju - 0,5 mg/ml - urbroj: 1 ml otopine za injekciju sadrži 0,5 mg neostigminijeva metilsulfata
heparin panpharma 5 000 iu/ml otopina za injekciju/infuziju
panpharma, z.i. du clairay, luitre, francuska - heparinnatrij - otopina za injekciju/infuziju - 5 000 iu/ml - urbroj: 1 ml otopine sadrži 5 000 iu heparinnatrija; jedna bočica s 5 ml otopine sadrži 25 000 iu heparinnatrija
rivastigmine 1 a pharma
1 a pharma gmbh - rivastigmin - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - simptomatsko liječenje blage do umjereno teške alzheimerove demencije. simptomatsko liječenje blage do umjereno teške demencije kod pacijenata sa idiopatskom parkinsonovom bolešću.
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
adepend 50 mg filmom obložene tablete
amomed pharma gmbh, leopold-ungar-platz 2, beč, austrija - naltreksonklorid - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg naltreksonklorida
contractubex 100 mg/g + 50 iu/g + 10 mg/g gel
merz pharmaceuticals gmbh, eckenheimer landstrasse 100, frankfurt/main, njemačka - ekstrakt lukovice luka heparinnatrij alantoin - gel - 100 mg + 50 iu + 10 mg/g - urbroj: 100 g gela sadrži 10 g ekstrakta (kao tekući ekstrakt) iz allium cepa l., bulbus (lukovica luka) (0,16 : 1, ekstrakcijsko otapalo: voda), 5000 iu heparinnatrija i 1 g alantoina
naltreksonklorid amomed 50 mg filmom obložene tablete
amomed pharma gmbh, leopold-ungar-platz 2, beč, austrija - naltreksonklorid - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg naltreksonklorida
hepa-merz 3 g granule za oralnu otopinu
merz pharmaceuticals gmbh, eckenheimer landstrasse 100, frankfurt/main, njemačka - l-ornitin-l-aspartat - granule za oralnu otopinu - 3,0 g - urbroj: 5 g granula (1 vrećica) sadrži 3,0 g l-ornitin-l-aspartata